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The single autosomal recessive gene lpr (lymphoproliferation) causes massive
lymphadenopathy and concomitant autoimmune disease when expressed in the
context of the MRL (1) or even normal background genes (2, 3) . Extensive
studies have been performed regarding the expanded population of cells in lpr
mice (4) . These cells exhibit rearrangements of TCR ,B chain genes (5, 6), but
not of Ig heavy chain genes (7), and therefore are probably ofT cell origin .
They manifest an immature T cell surface phenotype, i.e ., Thy-1+(dull), Ly-
1*(dull), Lyt-2- (8), L3T4- (9), and Paul-Bunnell-negative (P-B-)' (10) ; yet they
also have some B cell markers such as Ly-6 (11), 6B2, 3A1 (7), and PC-1 (12), as
well as high levels of9F3 antigen (13) . Increased expression ofthe c-myb oncogene
in these cells (14) further suggests their immaturity, since this proto-oncogene is
characteristic of immature T cells and of the hematopoietic stem cells (15) .
However, the lpr cells express mature TCR a chain (TCR-a) message (5, 6,
Croghan, T. W., J.-L . Davignon, J . Evans, J . P . Allison, R. A. Eisenberg, J . A.
Frelinger, and P. L . Cohen, submitted for publication) . Functional investigation
ofpurified Thy-1+,Lyt-2-,L3T4-(double-negative) lprT cellshas indicated their
inert (16) and immature nature (17) . It has thus been impossible to define the
differentiation stage of the abnormal lpr T cells, since they do not correspond
to any known normal subpopulations .
Some information is now available concerning the mechanisms of proliferation
of theseT cells . The fact that neonatal thymectomy prevents the later develop-
ment of lymphadenopathy indicates its thymus-dependent nature (18, 19) . The
operation of multiple factors, including some attributable to the spleen, was
claimed by using a technique of whole spleen organ transplantation (20) . Adop-
tive transfer experiments have shown that lymphadenopathy develops in lethally
irradiated MRL/Mp-lpr/lpr mice given MRL/Mp-lpr/lpr bone marrow (lpr/lpr
--* lpr/lpr) but not in those mice given MRL/Mp-+/+ stem cells (+/+ --), lpr/lpr)
(21-23) . These results suggest that hematopoietic precursor cells expressing the
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lpr gene are essential for the massive lymphadenopathy . However, the absence
of lymphadenopathy in (lpr/lpr --* +/+) chimeras suggests that the lpr host
environment is also important (22, 23) .
Two different mechanisms of lymphoproliferation can be postulated: (a) the
expanding lpr cell populations have an intrinsic defect(s) that causes unrestrained
growth; or (b) one set of abnormal lpr cells may induce a minor population of
normal cells to proliferate. The former hypothesis requires the lpr gene to be
expressed in the expanding cell population itself, while according to the latter it
may be expressed in other cells. To distinguish between these two potential
mechanisms, we used Ly-1 congenic mice in an adoptive bone marrow transfer
system . Bone marrow cell mixtures of B6-lpr/lpr (Ly-1 .2) and B6-+/+ (Ly-1 .1)
were transferred into lethally irradiated B6-lpr/lpr mice. This system enabled us
to trace the development of normal and lpr-derived stem cells in an lpr environ-
ment. Our results suggest that the lpr gene effect requires expression directly
within the T cells that accumulate in large numbers in lpr mice.
Materials and Methods
Mice.
￿
C57BL/6-lpr/lpr (B6-lprfpr), C57BL/6-Ly-1 .1 (B6/Ly-1 .1), and C57BL/6Kh
(B6/Kh) mice were obtained from The Jackson Laboratory, Bar Harbor, ME, and
maintained in our mouse colony.
Antibodies.
￿
A panel of rat mAbs was used in the form of culture supernatants. AT83
(24), specific for Thy-1 .2 ; GK-1 .5 (25), directed against L3T4; and 53-6.7, directed
against Lyt-2 (26), were originally supplied by Dr. Frank Fitch, University of Chicago,
Chicago, IL. Hybridoma cells secreting 3A1 mAb (anti-B220) were obtained from The
American Type Culture Collection, Rockville, MD . Culture supernatant containing 9F3
mAb was kindly donated by Dr. Francis Dumont, Merck Institute, Rahway, NJ. The
hybridomas that secrete mAb against Ly-1 .1 or Ly-1 .2 were kindly donated by Dr. U.
Hammerling, Sloan-Kettering Institute, New York, NY. Serum-free culture supernatants
were concentrated, and the mAbs were purified using protein A-coupled Sepharose 4B.
These antibodies were then biotinylated. FITC-coupled MAR 18.5 (mouse IgG2a mono-
clonal anti-rat K chain), phycoerythrin (PE)-coupled streptavidin, and FITC-coupled avidin
were purchased from Becton Dickinson & Co., Mountain View, CA.
Bone Marrow Cell Transfer.
￿
3-4-mo-old B6-lpr/lpr and B6/Ly-1 .1 mice of both sexes
were used as donors of bone marrow cells (BMCs). Femurs and tibias were removed
aseptically, and bone marrow was expressed by syringe via a 23-G needle into cold
Dulbecco's modified MEM buffered with 15 mM Hepes. 3-mo-old B6-lpr/lpr mice were
used as recipients and received water containing 2 g/liter ofantibiotic (Biosol 325; Upjohn
Co., Kalamazoo, MI) from 1 wk before irradiation until they were killed. They received
850 rad in a Gamma-cell 40 apparatus (Atomic Enemy ofCanada, Ltd., Ottawa, Canada) .
10 h after irradiation, they were injected with 10 B6-lpr/lpr (group I) or B6/Ly-1 .1
(group II) BMCs or with a mixture of 10' B6-lpr/lpr and 10' B6/Ly-1 .1 BMCs (group
III). All the recipients were housed in sterilizedcages in a room supplied with filtered air.
Assessment ofChimerism.
￿
The Ly-I allotype of lymphocytes of group III chimeras was
determined by cytotoxicity and immunofluorescence of mononuclear cells enriched from
peripheral blood by flotation on LSM (Litton Bionetics, Kensington, MD). Cytotoxicity
assays were performed according to the method ofJ. Klein et al. (27). Briefly, 2 J1 of the
cells (2 X l0') were incubated in a Microtest tissue culture plate (3034; Falcon Labware,
Oxnard, CA) for 20 min at room temperature with 2 ul of 1/20 dilution of either the
monoclonal anti-Ly-1 .1 or the monoclonal anti-Ly-1 .2. The mixture was washed and then
incubated for 30 min at 37°C with a 1/15 dilution of Low Tox-M rabbit complement
(Cedarlane, Willowdale, Ontario). The live and dead cells were distinguished through an
inverted phase-contrast microscope. For immunofluorescence, 3-5 X 105 cells were
incubated for 30 min at 4°C with a 1/20 dilution of biotinylated anti-Ly-1 .1 or anti-Ly-KATAGIRI ET AL.
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1 .2. The mixture was washed and then incubated with a 1/500 dilution of FITC-labeled
avidin. Cells were washed three times and preserved in 1 % formalin until flow cytometric
analysis.
Preparation of Cell Suspensions.
￿
Lymph nodes, spleens, and thymuses were removed
aseptically, and single cell suspensions were prepared in sterile RPMI 1640 (University of
North Carolina Cancer Center, Chapel Hill). Lymph node cells (LNCs) were from a pool
of all axillary, cervical, and mesenteric nodes. Their viability, as determined by trypan
blue exclusion, exceeded 90%.
Fluorescence Staining and Flow Microfluorometry Analysis.
￿
An indirect immunofluores-
cence protocol was used in all instances. HBSS (pH 7.2, UNC Cancer Center) containing
3% FCS (Hazelton Research Products, Denver, PA), 0.1% sodium azide, and 15 mM
Hepes buffer was used as the staining medium. Samples of 106 cells were incubated in
100 jul of staining medium for 30 min at 4°C with hybridoma supernatants or with
purified biotinylated anti-Ly-1 .1 or anti-Lyt-1 .2. Aftertwo washes, the cells were incubated
in 100 tal of staining medium for 30 min at 4° C with FITC-coupled anti-rat «, FITC-
coupled avidin, or PE-coupled avidin, as appropriate. Control samples were treated only
with FITC- and/or PE-coupled reagents. After an additional three washes, the cells were
analyzed by flow cytometry (Epics V; Coulter Electronics, Hialeah, FL). For two-color
immunofluorescence staining, both 9173 or 3A1 and biotinylated anti-Ly-1 .1 or anti-Ly-
1 .2 were added to the cells simultaneously, because none of these antibodies inhibited or
enhanced the binding of the other antibodies to the cells. Fluorescence data were plotted
logarithmically over a three-decade scale.
ELISA Assays.
￿
Serum levels of IgG antichromatin, IgG anti-ssDNA, and IgM rheu-
matoid factor were assayed in polyvinylchloride microtiter plates (Dynatech Laboratories,
Inc., Alexandria, VA) coated with chromatin (10 jug/ml, reference 28), ssDNA (10 tag/ml),
or IgGI myeloma protein MOPC245 (10 tag/ml), respectively, for 5 h at room tempera-
ture. Plates were then washed with borate-buffered saline (BBS) and nonspecifically coated
with coating buffer (BBS, 0.5% normal goat serum, 0.4% Tween-80, 0.5% BSA, 0.1%
NaN3) for 2 h. After the plates were washed, sera diluted at 1 :250 in coating buffer were
added and incubated overnight at 4°C. The plates were washed again, and affinity-
purified biotinylated goat anti-mouse y or goat anti-mouse 'U was added for 2 h of
incubation. After additional washing, the plates were incubated with avidin-linked alkaline
phosphatase (Sigma Chemical Co., St. Louis, MO) for 2 h. After further washings, 104
phosphatase substrate (para-nitrophenylphosphate, 1 mg/ml; Sigma Chemical Co.) was
added in 0.01 M diethanolamine, pH 9.8. The plates were read at appropriate intervals
with a microELISA autoreader (Dynatech Laboratories, Inc.).
Results and Discussion
Selective Expansion of the lpr/lpr-derived T Cell Populations in (lpr/lpr plus +/+
--* lpr/lpr) Chimeras. 3-mo-old B6-lpr/lpr (Ly-1.2) mice were lethally irradiated
(850 rad) and reconstituted with 107 BMCs from B6-lpr/lpr (Ly-1 .2) mice (group
1, lpr/lpr --+ lpr/lpr); from B6/Ly-1 .1 mice (group 11, +/+ --* lpr/lpr); or from
both strains of mice (group III, lpr/lpr plus +/+ --* lpr/lpr). Three control mice
not given BMC died within 1 mo after irradiation. 4 mo after BMC transfer, the
chimerism of 5 group III recipients was assessed by cytotoxicity and immunoflu-
orescence of PBMC with monoclonal anti-Ly-1 .1 and Ly-1 .2 . As shown in Table
1, the PBMC of these mice contained nearly equivalent numbers of Ly-1+ cells
of each donor allotype (Ly-1 .1+/Ly-1 .2+ = 0.88).
7-8 mo after the transfer, all mice were killed for examination. One of group
III had died just before sacrifice. Most mice in group I or group III had easily
detected submandibular lymphadenopathy, while all of group 11 mice looked
healthy at this time. To quantitate lymphoproliferation, the total numbers of744
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TABLE I
Chimerism ofGroup IIIMice (Ipr/lpr plus +/+ -). lpr/lpr)
Assay n*
TABLE II
Percentpositive of PBM
Ly-1 .1 Ly-1 .2
cytotoxicity
￿
3
￿
34, 36, 33
￿
36, 37, 39
immunofluorescence 2 30,32 41,38
* Number of mice tested. Five of eight mice in this group of chimeras
were examined.
Lymphoid Organ Cell Numbers andLy-1 Allotype ofLN Cellsin Bone Marrow Chimeras
Group
￿
Type oftransfer
Number of cells
￿
Percent positive of LN cells=
" Number ofmice examined.
I Percent positive of LN cells was determinedby immunofluorescence and cytofluorometry.
Values represent means ±SD.
splenocytes and LNC, and the Ly-1 allotype of the LNC were determined. As
shown in Table 11, remarkable splenomegaly and lymphadenopathy were ob-
served in both (Ipr/lpr --* lpr/lpr) and (lpr/lpr plus +/+ --* lpr/lpr) chimeras. In
contrast, the numbers of splenocytes and LNC of (+/+ --* lpr/lpr) chimeras were
similar to those of intact B6/Kh (Ly-1 .2) or B6/Ly-1 .1 mice. About 90% of the
lymph node T cells were Ly-1 .1 + in group II mice, which confirmed their
expected chimeric status. In group III chimeras, 70% ofthe cells in theexpanded
lymph nodes were Ly-1 .2+, while only 5% were Ly-1 .1 + (Ly-1 .1+/Ly-1 .2+ < 0.10;
Tables 11, 111, and Fig. 1) . Surprisingly, in contrast to the preferential reconsti-
tution of the lymph nodes by Ly-1 .2+ cells, the thymuses of the group III
chimeras were only moderately skewed toward the lpr phenotype (Ly-1.1+/Ly-
1.2+ = 0.70; Table 111, Fig. 2). This suggested either that lymphoproliferation
occurred mainly after emigration to the peripheral organs, or that excessive
emigration of lpr T cells from the thymus might result in massive peripheral
accumulation (29).
From these results taken together, we conclude: (a) the lpr T cell population
selectively expands in (lpr/lpr plus +/+ -> lpr/lpr) chimeras; (b) in these mice,
+/+ lymphocytes neither prevent the growth of lpr T cells, nor proliferate in
the environment where the lpr gene is fully expressed; (c) +/+ lymphocytes
cannot proliferate abnormally in lpr/lpr host mice even when they constitute
90% of the population of lymph node cells; and (d) the abnormal accumulation
of T cells caused by the lpr gene occurs in the peripheral organ(s), but not in the
thymus.
Phenotypic Similarity of the Expanded T Cell Population in (lpr/lpr plus +/+
spleen
x10-e
LN
x10-'
Thy-l.2 Ly-1.1 Ly-1.2
I lpr/Ipr- Ipr/lpr 5 2.2 ±0.44 20 ±6.6 76 ± 3.2 1 .8 ± 1.3 67 ± 2.2
11 +/+-.1pr/1pr 5 0.8 ±0.1 2.2 ±0.3 69 ±4.0 59 ± 3.6 7.0 i 3.2
III lpr/lpr plus +/+-. lpr/lpr 7 1.9 ±0.5 20 ±6.9 76 ±5.3 5.1 ± 1.1 691- 3.5
Unmanipulated
B6/Kh 4 1 .0±0.1 2.3±0.3 70±3.1 1 .5±1.7 6015.6
156/1-y-1.1 4 1 .0 ± 0.1 2.4 ±0.3 68 ±2.1 57 ± 1.8 1.5 ± 1 .2w
m
Z
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W
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FLUORESCENCE INTENSITY
FIGURE 1. Fluorescence pro-
files of lymph node cells from
(lpr/1pr -s lpr/lpr) (a and b) (+/+
-rlpr/1pr (candd) or (lpr/lpr plus
+/+-*lpr/lpr) (e andf) chimeras
stained with monoclonal anti-Ly-
1.1 (a, c, ande) or anti-Ly-1.2 (b,
d, and f). Background staining
with FITC-avidin alone is also
shown in each profile.
TABLE III
Ly-1 Allotype of Thymocytesfrom GroupIII(lpr/lpr plus +/+ --* lpr/lpr) Chimeras
* Ly-1 positive percent of the cellswas determined by immunofluorescence.
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lpr/lpr) Chimeras to that of Intact lpr Mice.
￿
Next, we investigated the surface
differentiation antigens on the T cells of (lpr/lpr plus +/+ --* lpr/lpr) chimeras
to assess whether or not these cells were identical to those accumulating in intact
lpr mice . As shown in Fig. 3, the majority of the cells in the chimeras was Thy-
1+ (Fig. 3a), Ly-1 .2+ (Fig. 3b), L3T4-,Lyt-2- (Fig. 3c). The amounts of both
Thy-1 and Ly-1 antigens on the surface of these cells were less than those on
LNC of intact B6/Kh mice (Fig. 3, d and e). We also stained for the 9F3 and
3A 1 (B-220) antigens, which are known to be expressed on the expanded T cell
population of lpr mice (7, 13). As shown in Fig. 4, a remarkable increase in Ly-
1.2+, 9F3+ (Fig. 4a) and Ly-1 .2+, 3A1+ (Fig. 4d) cells was observed in (lpr/lpr
plus +/+ -)- lpr/lpr) chimeras, as compared with (+/+ --* lpr/lpr) chimeras (Fig.
4, b and e) or intact B6/Kh mice (Fig. 4, c andf). Neither 9F3 nor 3A1 antigens
Number of Percent positive*
Mouse
Number LN cells Thymocytes
LN
Ly-1 .1
cells
Ly-1.2 Ly-1 .1
Thymocytes
Ly-1 .2
x10-7 x10-7
1 30 1.3 5 71 38 55
2 19 1.7 6 65 32 46
3 16 1.2 6 69 35 50
4 21 1.8 5 73 40 58
5 27 ND 3 70 ND ND
6 13 1.3 5 69 37 50
7 11 ND 6 63 ND ND746
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FIGURE 3 .
￿
Comparison of the expression ofThy-1 .2 (a and d) Ly-1 .2 (b and e) or Lyt-2 plus
L3T4 (c andf) on lymphnode cells from an (lpr/lpr plus +/+ -* lpr/lpr) chimera (a, b, and c)
and an unmanipulated B6/Kh mouse (d, e, and f) . Background staining with FITC-avidin
alone isalso shown in each profile . These data are representative ofthree separate experiments .
b
FLUORESCENCE INTENSITY
FLUORESCENCE INTENSITY (GREEN)
FIGURE 2 .
￿
Fluorescence profiles of thymocytes from a
representative (lpr/lpr plus +/+ --* lpr/lpr) chimera
stained with biotinylated monoclonal anti-Ly-1 .1 (a) or
anti-Ly-1 .2 (b) . Background staining with FITC-avidin
alone is also shown in each profile .
c Lyt2 + L3T3
A.
Lyt 2+L3T "
FIGURE 4 . Two-color fluorocytome-
tric analysis of 9F3 (a, b, and c; green)
or 3A1 (d, e, andf, green) and Ly-1 .2 (a,
c, d, andf, red) or Ly-1 .1 (b, and e ; red)
antigens on lymph node cells from an
(lpr/lpr plus +/+~ lpr/lpr) chimera (a
and d), a (+/+~ lpr/lpr) chimera (b and
e), or an unmanipulated B6/Kh mouse (c
and f) . The levels that show <1% posi-
tive for both greenand red fluorescence
of lymph node cells treated with
counterstains alone are delimited by the
lines . These data are representative of
three separate experiments .were expressed on the minor population of Ly-1 .1 + LNC of group III chimeras
(data not shown).
These data indicate that the major population of T cells in (lpr/lpr plus +/+
---> lpr/lpr) chimeras is Thy-1+(dull), Ly-1 .2+(dull), Lyt-2-,L3T4", 9F3+,3A1 +,
which is identical to that seen in intact lpr mice.
Autoantibody Formation in Chimeras.
￿
Finally, the serum levels of three auto-
antibodies, IgG antichromatin, IgG anti-ssDNA, and IgM rheumatoid factor,
were assessed in the three groups of chimeras and compared with those of
unmanipulated B6-lpr/lpr, B6/Kh, and B6/Lyl .l mice (Table IV). Both the
group I (lpr/lpr --* lpr/lpr) and the group III (lpr/lpr plus +/+ -~ lpr/lpr) sera
hadelevated levels of all three autoantibodies, while the groupII (+/+ --* lpr/lpr)
sera exhibited no more activity than normal controls. These data confirm that
the lpr internal milieu alone cannot induce autoantibody formation in normal
lymphocytes (22, 23). Furthermore, the similar autoantibody levels of the intact
B6-lpr/lpr mice compared with the group III chimeric mice (which presumably
possess a full complement of normal T cells) indicate that autoantibody produc-
tion in lpr mice cannot be suppressed by normal T cells and thus is not due to a
lack of T suppressor cells.
Recently, Perkins et al. (30) demonstrated that MRL/lpr recipient mice were
resistant to engraftment by normal A-Thy mouse lymphocytes and that (A-Thy
--* MRL/lpr) radiation chimeras were completely repopulated by MRL/lpr
lymphocytes within 6 wk after transplantation . Our experimental system differs
from theirs in that we have used as donors 99% genetically identical, congenic
+/+ mice (instead of A-Thy mice). We found <10% repopulation by residual
host bone marrow in (+/+ --* lpr/lpr) chimeras 7 mo after the transplantation.
However, Perkins' data suggest the existence of radioresistant effector cells that
may attack and prevent the growth and differentiation of +/+ lymphocytes or
precursors in the lpr host mice. Nevertheless, in our experiments we detected
normal numbers of Lyt-2+ and/or L3T4+ T cells in (+/+ ---* lpr/lpr) chimeras
(data not shown). In addition, Ly-1 .1 +, +/+-derived cells constituted 33 and
36% of the cells in the peripheral blood and the thymus, respectively, of (lpr/lpr
KATAGIRI ET AL.
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TABLE IV
Serum Autoantibody Levels in Bone Marrow Chimeras
* Size of each group.
$ Values representmeans ±SD ofOD,o5 in ELISA.
4 Theseare significantly different from those of unmanipulated normal mice, p < 0.05 (Student's t
test).
Group Type of transfer n* IgG
antichromatin$
IgG
anti-ssDNA* IgM RF
I lpr/lpr-~- lpr/lpr 5 0.362 ± 0.060 0.434 ± 0.0915 0.384 ± 0.1354
II +/+---> lpr/lpr 5 0.105±0.039 0.089±0.051 0.113±0.010
III lpr/lprplus +/+--* lpr/lpr 7 0.504±0.157§ 0.659±0.218§ 0.416±0.100§
Unmanipulated
B6-lpr/lpr 4 0.548±0.059§ 0.684±0.132§ 0.453±0.149§
B6/Kh 4 0.053 ± 0.010 0.074 ± 0.013 0.075 ± 0.024
B6/Ly1.1 4 0.100 ± 0.022 0.089 ± 0.031 0.123 ± 0.033748
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plus +/+ --* lpr/lpr) chimeras. Therefore, marked suppression of the +/+
precursors in the lpr host did not occur in our system.
Our data support the hypothesis that the lpr gene causes intrinsic defect(s) in
the T cells which hyperproliferate to form massive lymphadenopathy. We cannot
exclude the possibility that an additional abnormality in the lpr internal milieu
or in another subset of the cells, such as macrophages, might be associated with
the triggering mechanism of the lymphadenopathy (31). However, such an
abnormality alone is not sufficient, and the defect(s) in the expanding cell
population itself is essential for the disease. An aberrant response of lpr T cells
to growth-regulation lymphokine(s), or to autocrine growth mechanisms could
explain the unrestrained growth of these cells, but confirmation of these possi-
bilities is lacking (32). From the recent molecular approaches for the lprT cells,
we can speculate that the candidate defect(s) of lpr T cells could include:
enhanced expression of c-myb and c-rafoncogenes (14); defects in regulation of
c-myc oncogene expression (Katagiri, K., T. Katagiri, S. Yokota, R. A. Eisenberg,
P. L. Cohen, and J. Ting, submitted for publication) ; altered K+ channel
expression (33); aberrant expression of surface glycoprotein and glycolipid (34);
and abnormal phosphorylation of tyrosine residues of membrane protein (35;
our unpublished observation). Although it is impossible to determine at this
point which, if any, of these reported abnormalities are directly relevant to the
lpr lymphoproliferation, our current data increase our confidence that the
expanded, double-negative T cell population itself directly expresses the lpr gene
defect.
Summary
Thelpr gene induces marked lymphoproliferation characterizedby themassive
accumulation of T cells of an unusual phenotype and concomitant autoimmune
disease. To clarify the mechanism of the lpr effect, bone marrow cells from B6-
lpr/lpr (Ly-1.2) and B6-+/+ (Ly-1.1) mice were transferred into lethally irradi-
ated B6-lpr/lpr mice. As has been previously reported, recipients of the B6-
lpr/lpr bone marrow showed the typical lpr phenotype with marked lymphade-
nopathy, splenomegaly and increased levels of autoantibodies; while the recipi-
ents of B6-+/+ bone marrow had normal sized lymph nodes and spleen and no
autoantibodies. A third group of mice received an equal mixture of bone marrow
cells from the B6-lpr/lpr and B6-+/+ donors. These mice showed both lymph-
adenopathy and autoantibody production comparable to that of recipients of the
B6-lpr/lpr marrow alone. Immunofluorocytometric analysis of the lymphoid
populations in these mixed bone marrow recipients established that the T cells
from the lpr/lprand +/+ donors were equivalently representedin the peripheral
blood and thymus. In striking contrast, the T cells that accumulated in abnor-
mally large numbersin the lymph nodes were almost entirely from the lpr donor.
Their surface phenotype was Thy-1+(dull), Ly-1 .2+(dull), Lyt-2-, L3T4-, 9F3+,
and 3A1+, which is consistent with that found in intact lpr mice. These results
indicate that the lpr gene causes an intrinsic defect directly within the T cells
that accumulate in large numbers in lpr mice. In addition, the presence of the
+/+ T cells cannot prevent the expression of the lpr abnormalities.KATAGIRI ET AL.
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